-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report) traded up 5.9% during mid-day trading on Wednesday . The stock traded as high as $6.27 and last traded at $6.14. 877,218 shares were traded during trading, a decline of 74% from the average session volume of 3,376,665 shares. The stock had previously closed at $5.80.
Mind Medicine (MindMed) Trading Up 5.9 %
The company has a 50 day simple moving average of $7.30 and a 200-day simple moving average of $8.04.
Mind Medicine (MindMed) Company Profile
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Featured Articles
- Five stocks we like better than Mind Medicine (MindMed)
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Introduction to Fibonacci Retracement Levels
- ETF Screener: Uses and Step-by-Step Guide
- Top 3 Stocks to Outperform the S&P 500 in a Downturn
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
